NASDAQ
Hemogenyx Pharmaceuticals Plc (HOPHF) has a fcf yield of -44.93% as of Tuesday, August 4, 2026. This represents a 99.73% increase compared to its 12-month average of -16868.53%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.